These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3226649)

  • 21. Treatment approaches in Gilles de la Tourette syndrome.
    Borison RL; Ang L; Hamilton WJ; Diamond BI; Davis JM
    Brain Res Bull; 1983 Aug; 11(2):205-8. PubMed ID: 6578865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of clonidine response in Tourette syndrome: implications and inferences.
    Lichter DG; Jackson LA
    J Child Neurol; 1996 Mar; 11(2):93-7. PubMed ID: 8881983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 2).
    McDaniel KD
    Clin Pediatr (Phila); 1986 Mar; 25(3):143-6. PubMed ID: 2868821
    [No Abstract]   [Full Text] [Related]  

  • 24. Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder.
    Seo WS; Sung HM; Sea HS; Bai DS
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):197-205. PubMed ID: 18439116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Life events and Tourette syndrome.
    Steinberg T; Shmuel-Baruch S; Horesh N; Apter A
    Compr Psychiatry; 2013 Jul; 54(5):467-73. PubMed ID: 23219489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders.
    Steingard R; Biederman J; Spencer T; Wilens T; Gonzalez A
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):350-3. PubMed ID: 8444764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tic symptom profiles in subjects with Tourette Syndrome from two genetically isolated populations.
    Mathews CA; Jang KL; Herrera LD; Lowe TL; Budman CL; Erenberg G; Naarden A; Bruun RD; Schork NJ; Freimer NB; Reus VI
    Biol Psychiatry; 2007 Feb; 61(3):292-300. PubMed ID: 16581034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pharmacotherapeutic rationale for the use of lithium carbonate in Tourette's syndrome.
    Messiha FS
    Proc West Pharmacol Soc; 1979; 22():27-9. PubMed ID: 292979
    [No Abstract]   [Full Text] [Related]  

  • 29. Tic reduction with pergolide in a randomized controlled trial in children.
    Gilbert DL; Dure L; Sethuraman G; Raab D; Lane J; Sallee FR
    Neurology; 2003 Feb; 60(4):606-11. PubMed ID: 12601100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
    Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and clinical profiles of Tourette's disease: a comprehensive overview.
    Messiha FS; Carlson JC
    Brain Res Bull; 1983 Aug; 11(2):195-204. PubMed ID: 6414653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary evaluation of child self-rating using the Child Tourette Syndrome Impairment Scale.
    Cloes KI; Barfell KS; Horn PS; Wu SW; Jacobson SE; Hart KJ; Gilbert DL
    Dev Med Child Neurol; 2017 Mar; 59(3):284-290. PubMed ID: 27671877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of Tourette syndrome and its comorbidity: experience with 17 cases].
    Martínez-Granero MA; Montañés Rada F; García Pérez A; de Lucas Taracena MT; Sánchez Romero S; Rafia S; Granados A; Parra Cuadrado E
    Neurologia; 2005 Dec; 20(10):678-85. PubMed ID: 16317589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium carbonate in Gilles de la Tourette's disease.
    Messiha FS; Erickson HM; Goggin JE
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):609-12. PubMed ID: 1069354
    [No Abstract]   [Full Text] [Related]  

  • 35. Differences in 99mTc-HMPAO brain SPET perfusion imaging between Tourette's syndrome and chronic tic disorder in children.
    Chiu NT; Chang YC; Lee BF; Huang CC; Wang ST
    Eur J Nucl Med; 2001 Feb; 28(2):183-90. PubMed ID: 11303888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The somatotopy of tic inhibition: Where and how much?
    Ganos C; Bongert J; Asmuss L; Martino D; Haggard P; Münchau A
    Mov Disord; 2015 Aug; 30(9):1184-9. PubMed ID: 25786675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.
    Gilbert DL; Murphy TK; Jankovic J; Budman CL; Black KJ; Kurlan RM; Coffman KA; McCracken JT; Juncos J; Grant JE; Chipkin RE
    Mov Disord; 2018 Aug; 33(8):1272-1280. PubMed ID: 30192018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.
    Rizzo R; Gulisano M; Calì PV; Curatolo P
    Eur J Paediatr Neurol; 2013 Sep; 17(5):421-8. PubMed ID: 23473832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome.
    Pappert EJ; Goetz CG; Louis ED; Blasucci L; Leurgans S
    Neurology; 2003 Oct; 61(7):936-40. PubMed ID: 14557563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An exploratory study into an adapted use of the Alert Program for tic disorder in children.
    Soler N; Hardwick C; Perkes IE; Dossetor D; Bray P; Dale RC
    Australas Psychiatry; 2019 Apr; 27(2):144-151. PubMed ID: 30501513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.